What does 503A compounding actually mean?

503A is the section of federal law covering traditional, patient-specific compounding pharmacies, the kind that fill one named patient’s prescription at a time. 503B is a separate section for outsourcing facilities that batch-produce without a prescription in hand. Neither one makes an FDA-approved drug, which is the distinction that actually matters once you get past the label.

“503A” and “503B” show up constantly in telehealth marketing and in the fine print of medication offers, usually with no explanation of what the numbers mean. They refer to two sections of the federal Food, Drug, and Cosmetic Act that govern pharmacy compounding, and the difference between them determines what a pharmacy is legally allowed to make and how.

503A: traditional, patient-specific compounding

A 503A pharmacy is what most people picture when they hear “compounding pharmacy”: a licensed pharmacy that prepares a medication for one named patient, based on a valid prescription from that patient’s prescriber. 503A compounding exists to fill a real clinical gap, a strength or formulation that is not commercially manufactured, an allergy to an inactive ingredient, a liquid version of a tablet for a patient who cannot swallow pills. It is regulated primarily at the state pharmacy board level, with FDA oversight layered on top.

503B: outsourcing facilities

A 503B outsourcing facility is a different category entirely. These facilities can compound in larger batches, without a patient-specific prescription in hand at the time of production, and they sell to hospitals and clinics rather than directly filling one patient’s order. In exchange for that scale, 503B facilities register with the FDA and follow current Good Manufacturing Practice standards, which is a higher bar than a standard 503A pharmacy but still short of full drug approval.

What neither one does

This is the part that gets lost in marketing copy: neither 503A nor 503B produces an FDA-approved drug. Compounded medications, whether from a 503A pharmacy or a 503B facility, are not reviewed by the FDA for safety or effectiveness the way a brand-name drug is before it reaches the market. That is true even when the facility itself is properly registered and inspected. Registration and inspection are about the facility’s process, not a review of the specific compounded product’s clinical data.

When compounding is legitimate

Compounding earns its place in medicine when it solves a real, individual problem that a commercially manufactured drug cannot. A prescriber writes an order for a specific patient, a licensed pharmacy fills it, and the reason for compounding rather than dispensing the standard product is documented and clinically sound. Classic examples include a pediatric patient who needs a liquid suspension of a medication that only comes as a tablet, an adult with a documented allergy to a dye or preservative in the commercial formulation, or a hospital that needs a sterile preparation compounded to exact specifications for a single procedure.

There is also a narrow, federally recognized shortage exception: when a commercially manufactured drug is officially listed as being in shortage, compounding pharmacies may produce a version of it as a stopgap until supply recovers. That exception is meant to be temporary, tied to the shortage listing itself, not a permanent substitute once the shortage ends.

The red flag to watch for

The pattern worth being cautious about is compounding used as a permanent, large-scale substitute for a commercially available, FDA-approved drug, marketed on price rather than on a genuine clinical need. If a telehealth offer leans on the words “503A” or “503B” as a selling point rather than a disclosure, and cannot clearly explain why compounding is medically necessary for you specifically, that is worth a second look before you commit.

For how this shapes our own medication programs, see our standards page.

This article is general regulatory information, not legal or medical advice, and does not name or endorse any specific pharmacy.